FDA Must Strive for Progress, Not Perfection

more+
less-

When it comes to research on promising new classes of pain therapies, the agency must weigh its understandable caution regarding safety concerns against unmet needs of millions of patients suffering with pain.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Michael Barnes, DCBA Law & Policy | Attorney Advertising

Written by:

more+
less-

DCBA Law & Policy on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×